Evoke Neuroscience is a leading player in computational EEG for brain health, focusing on creating tools to assist physicians in diagnosing cognitive impairment. Established in 2009, the company is committed to enhancing patient health through brain-focused initiatives. Evoke Neuroscience's FDA-cleared eVox® Brain Health System empowers physicians to utilize brain biomarkers for differential diagnoses and early identification of cognitive impairment. Specializing in the Health Care and Medical Devices industries, the company has been at the forefront of making comprehensive brain health scans routine and accessible for a wide audience. Although details concerning their headquarters and recent investments remain undisclosed, Evoke Neuroscience's dedication to advancing brain health and cognitive diagnosis presents an intriguing opportunity for potential investors in the medical technology sector.
There is no investment information
No recent news or press coverage available for Evoke Neuroscience.